Significant Advances in HIV Research and Treatment: A New Era of Hope
As the world prepares to observe the 37th World AIDS Day on December 1, 2024, there is a palpable sense of optimism and progress in the fight against HIV. Recent developments, particularly in Spain, highlight the groundbreaking work being done to combat this disease.
Gilead Sciences Acquires Promising HIV Vaccine Assets
In a major milestone, Gilead Sciences has acquired the investigational assets for the HTI therapeutic HIV vaccine from AELIX Therapeutics, a Barcelona-based biopharmaceutical company. This vaccine, developed by researchers at IrsiCaixa, including Christian Brander, Beatriz Mothe, and Anuska Llano, has shown promising results in phase 1 and phase 2 clinical trials.
Read more ->